Insider Buying: Enhabit, Inc. (NYSE:EHAB) Director Acquires $132,150.00 in Stock

Enhabit, Inc. (NYSE:EHAB) Director Stuart M. Mcguigan acquired 15,000 shares of the business’s stock in a transaction dated Tuesday, December 10th. The shares were bought at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the transaction, the director now directly owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Enhabit Stock Performance

Shares of EHAB stock opened at $8.52 on Friday. The company has a market cap of $428.39 million, a P/E ratio of -3.67 and a beta of 1.89. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a fifty day moving average price of $7.56 and a 200 day moving average price of $8.31. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $11.74.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter in the prior year, the firm posted $0.03 EPS. Sell-side analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on EHAB shares. Leerink Partners reissued a “market perform” rating and set a $8.00 target price (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $8.75.

Hedge Funds Weigh In On Enhabit

Several large investors have recently bought and sold shares of the stock. FMR LLC lifted its holdings in shares of Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after purchasing an additional 1,967 shares during the last quarter. Gladius Capital Management LP acquired a new position in Enhabit during the second quarter worth approximately $31,000. Quarry LP lifted its stake in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after buying an additional 2,621 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new stake in shares of Enhabit in the third quarter valued at approximately $81,000. Finally, Canada Pension Plan Investment Board purchased a new position in Enhabit during the 2nd quarter worth $93,000.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.